Orally bioavailable prodrugs of (+)-3-hydroxymorphinan for Parkinson's disease prevention or treatment

摘要

The present invention is directed to a novel prodrug of (+)-3-hydroxymorphinan compound of formula (I) or a pharmaceutically acceptable salt thereof, a method for preparing the same, and its use for preventing or treating Parkinson's disease.